Indirubin Derivative E804 NEW
| Price | Get Latest Price |
| Package | 1removed |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: Indirubin Derivative E804 | CAS No.: 854171-35-0 |
| Purity: 98.75% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | Indirubin Derivative E804 |
| Description | Indirubin Derivative E804 is a potent insulin-like growth factor type 1 receptor (IGF1R) inhibitor with potential antitumor activity. |
| In vitro | Indirubin Derivative E804 is a water-soluble derivative that effectively inhibits insulin-like growth factor 1 receptor (IGF1R) with an IC50 of 0.65 μM. In addition, Indirubin Derivative E804 also inhibits CDK2/CycE with an EC50 of 0.23 μM. [1] |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 135 mg/mL (369.48 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (27.37 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (27.37 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | Indirubin Derivative E-804 | Indirubin Derivative E804 | Indirubin Derivative E 804 | IGF-1R | IGF1R |
| Inhibitors Related | Insulin (human) | Urolithin C | BMS-754807 | Morin | Ornithine-α-ketoglutarate | (2S,3R,4S)-4-Hydroxyisoleucine | Picropodophyllin | Sorbic acid | Brigatinib | L-Cysteine hydrochloride hydrate | Tranexamic acid | Linsitinib |
| Related Compound Libraries | Anti-Lung Cancer Compound Library | Glycometabolism Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Kinase Inhibitor Library | Bioactive Compound Library Plus | Inhibitor Library | Metabolism Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY